August 21, 2024
Africa is grappling with a pressing health challenge – diabetes. The region is set to register the highest increase in the number of people with diabetes of all regions. With approximately 24 million adults affected and significant disparities in care, a 129% increase to 783 million is expected by 2045. From prevalence and resource access to policy frameworks and healthcare infrastructure, diabetes care delivery in the region is confronted with myriad complexities. However, by implementing successful initiatives and decisive recommendations that address underlying obstacles, we can improve diabetes care and prevention to improve health outcomes for millions in the region.
Diabetes prevalence and incidence, drivers of the diabetes epidemic
According to the latest estimates released by the International Diabetes Federation (IDF) in 2021, approximately 24 million adults aged 20-79 are living with diabetes in the region. More than half (13 million) are undiagnosed. Furthermore, an estimated 52 million adults have impaired glucose tolerance, which places them at high risk of developing type 2 diabetes.
The same factors that have contributed to the diabetes surge in China and India are contributing to the rise in type 2 diabetes in Africa. These include lifestyle and dietary changes, urbanisation and socioeconomic influences, all compounded by an ageing population, decreasing levels of physical activity and an increasing prevalence of people with overweight and obesity. In addition, challenges with early diagnosis and access to care further exacerbate the diabetes burden in the region. Often people do not know or do not notice the symptoms of diabetes until they are hospitalised or diagnosed with a diabetes-related complication.
Disparities in the prevalence and incidence of diabetes exist across countries in Africa. While some countries may have higher prevalence rates due to socioeconomic and demographic factors, others may struggle with accurate data collection and reporting, leading to underestimation of the impact of diabetes.
Furthermore, unequal access to diabetes medications and technologies negatively impacts diabetes care. In some countries, challenges in procuring essential diabetes medicines and technologies lead to inadequate management and care for people with diabetes.
Access to insulin
One recurring issue is the availability of insulin, an essential treatment for people with type 1 diabetes and many with type 2 diabetes and other forms of the condition. Rising prices and the shortage of insulin and diabetes supplies in some countries have hindered access for people with diabetes. Consequently, many young people with type 1 diabetes go without their diabetes treatment to make ends meet. Advocacy efforts in the region call on governments to ensure the availability of insulin in public hospitals so people with diabetes do not have to pay out-of-pocket for their diabetes treatment.